Active — Not RecruitingNot Applicable

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:

France500 participantsStarted 2014-11-18

Plain-language summary

Adjuvant radiotherapy after lumpectomy allows a local long-term control of the order 85 to 95% with a survival rate equivalent to that of the totally mastectomy. The diminution of the local recurrence rate after irradiation post- lumpectomy is also associated to a best global survival than only the surgery. The adjuvant radiotherapy after partially or totally mastectomy for the progressive tumors is a therapeutic standard (Early Breast Cancer Trialists' Collaborative Group 2011). The aim of our trial of routine care is to record our practices under this breast adjuvant radiotherapy.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. \- Metastatic disease
✕. \- Patient having another severe disease or uncontrolled which could jeopardize the trial participation
✕. \- pregnant or breastfeeding woman 4-inability to do follow-up medical care of clinical trial for geographical, social or psychological reasons

What they're measuring

acute and tardive toxicity according to NCI-CTCAE v4.0

Timeframe: up to 5 years

Trial details

NCT IDNCT02281149

SponsorCentre Oscar Lambret

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Breast Cancer trials